GVR Report cover Transplantation Market Size, Share & Trends Report

Transplantation Market Size, Share & Trends Analysis Report By Product Type (Tissue Products, Immunosuppressive Drugs), By Application Type (Organ, Tissue Transplant), By End-use, And Segment Forecasts, 2021 - 2028

  • Published Date: Jan, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-1-68038-864-0
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 110

Report Overview

The global transplantation market size was valued at USD 8.4 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 11.5% over the forecast period. Growing demand for novel tissue transplantation products and organ transplantation for the treatment of organ failure is a major factor contributing to the market growth. Organ failure usually occurs due to various factors, such as serious trauma, loss of blood, poisoning, drug abuse, leukemia, sepsis, and other acute diseases. For instance, diabetes and high blood pressure are the most common causes of end-stage renal disease, where kidney transplant or dialysis are the only treatment options to keep a patient alive. Demand for tissue and organ transplantation, mainly kidney, heart, liver, and lungs, is very high globally. According to the U.S. Department of Health & Human Services, there were around 122,913 patients in the U.S. waiting to receive organs for transplant in 2019. Unhealthy dietary habits, alcohol consumption, and lack of exercise are some other leading causes of organ failure.

The U.S. transplantation market size, by product type, 2016 - 2028 (USD Billion)

The introduction of technologically advanced products and an increasing number of tissue banks are also boosting the market growth. However, some factors, such as the shortage of organ donors for transplantation procedures, are expected to restrain the market growth. There is a huge gap between the demand and supply of organs for organ failure treatment, which is attributed to various religious & customary beliefs and lack of awareness about organ donation.

According to the U.S. Department of Health & Human Services, in 2019, there were around 43,201 patients waiting for kidney transplants in the U.S. However, only 23,401 kidney transplant procedures were performed. Moreover, after a transplantation surgery, the recipients are prescribed powerful immunosuppressive drugs; thus, increasing their susceptibility to infectious diseases with their immunity being weakened.

COVID19 impact: Market declined by 50% in 2020

Pandemic Impact

Post COVID Outlook

Total transplantation procedures were down to around 50% globally during the first and second quarters of 2020.

Surgeons are now able to transplant organs even in COVID-19 recovered patients. However, post-transplantation patients are at higher risk of COVID-19 and the number of procedures is expected to be limited during 2021.

Many of the transplant centers have started solid organ transplants despite the second wave of the pandemic. For COVID-19 patients, the procedures are performed after 4 weeks of infection.

Organ failures related to permanent damage due to COVID, and an increasing geriatric population are the factors expected to fuel the market during the forecast period. The growth rate is expected to be increased by 2-3% as compared to the CAGR forecasted with non-COVID scenario


This can hamper the demand for transplantation procedures in many countries amid the global COVID-19 pandemic. In addition, the shortage of resources, such as primary protective equipment, ICU, and blood products, during the pandemic has contributed to the sharp fall in the market revenue in 2020.

Product Type Insights

The tissue products segment was the highest revenue-generating product type segment in 2020 and accounted for a market share of over 57%. Major products used for tissue or organ transplant are tissue products, immunosuppressants, and preservation solutions. The increasing demand for transplantation procedures, such as that of cochlear, heart valves, bone marrow, and orthopedic soft tissues, is attributing to the growth of the segment. In addition, new product development is fueling the market growth. For instance, in September 2015, Arthrex Inc. launched ArthroFlex Acellular Dermal Matrix, a new orthobiologic product that is intended for use in capsular reconstruction. This product allows retention of its growth factors and native collagen scaffold and elastin and allows transplant to be successfully incorporated into the receiver.

Manufacturers are focusing on new product development, mergers & acquisition, and collaborations to expand their current product portfolio and reinforce their position in the industry. For instance, in September 2016, Stryker Corporation acquired Instratek, a leading manufacturer of minimally invasive soft tissue recession instruments for the ankle, foot, and upper extremity procedures.

The immunosuppressive drugs segment is projected to showcase the fastest CAGR during the forecast period. This can be attributed to the high usage of these drugs to prevent post-transplant tissue or organ rejection. The increasing prevalence of chronic diseases has led to a rise in demand for organ replacements. Thus, demand for immunosuppressive drugs is expected to grow at a significant pace during the forecast period.

The preservation solutions segment is expected to exhibit significant growth during the study period due to government support for stem cell research and the high scope of application of these products to improve the physiological function of organs. In addition, growing cases of organ failure and increasing demand for organ transplant procedures are expected to drive the segment growth.

Application Type Insights

Tissue transplantation led the global transplantation market with a share of over 61% in 2020 and the segment will expand further at the fastest CAGR from 2021 to 2028. This is due to the fact that replacement of skin, cornea, bones, heart valves, tendons, nerves, and veins are the most commonly performed procedures worldwide. The escalating number of burn and accident cases is expected to propel the demand for tissue products. According to the European Road Safety Observatory report, there were 102,362 accidental injury cases reported in Spain, thus, creating a demand for tissue transplantation.

The organ transplantation segment is expected to register a significant growth rate of 10.8% during the forecast period. An increasing number of organ transplantations globally as well as the repetitive purchase of immunosuppressants is anticipated to boost the market growth in the near future. For instance, in 2017, globally, around 90,306 kidney transplant procedures were performed.

Global transplantation market share, by application type, 2020 (%)

Advancements in transplantation technology and the launch of new products by manufacturers are expected to propel the number of transplant procedures, especially for organs including the kidney, liver, heart, lungs, and tissues. For instance, in November 2020, Lupin announced the launch of generic immunosuppressant drug Tacrolimus in the U.S. market, indicated for prophylaxis of organ rejection in the allogeneic liver, kidney, and heart transplant.

In 2020, a high number of transplant procedures was documented in the U.S., Germany, U.K., and France, and this number is expected to increase in the coming years. The presence of well-developed healthcare infrastructure and availability of expert surgeons & advanced products are some key factors driving the market growth in these countries.

End-use Insights

The hospital segment held the largest revenue share of over 49% in 2020. A large number of organ and tissue transplant procedures are conducted at hospitals as they are primary treatment centers. In addition, the emergence of hospitals with developed infrastructure is expected to fuel segment growth. The majority of these hospitals have access to well-defined databases to check for the availability of organs aiding in rapid medical intervention.

The transplant centers segment is expected to exhibit the highest CAGR over the forecast period. Rising demand for transplantation procedures has triggered the need for advanced healthcare centers. Also, rising government initiatives to encourage organ donation is projected to propel the segment growth. For instance, the Health Resources and Services Administration’s Division of Transplantation sponsored four grant programs that focus on increasing the number of organ donors and transplant procedures.

The presence of established healthcare infrastructure and advanced transplant centers in the U.S., France, the U.K., and other European countries will boost the demand for advanced transplant products in these countries. For instance, according to the National Kidney Center, there are around 244 kidney transplant centers in the U.S. Rising number of organ donors, growing burden of acute and chronic diseases such as high blood pressure and diabetes, and improving healthcare infrastructure in developing economies such as China, India, Argentina, and Brazil, are expected to propel the segment growth in the emerging regions as well.

Regional Insights

North America led the global market in 2020 with a share of over 39% and is expected to maintain its dominance throughout the study period. The presence of well-developed healthcare facilities and several large-scale biotechnology and medical devices companies, such as Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; and Stryker, in the region are supporting the market growth.

The gap between demand and supply of organs, including kidney, liver, and heart, for transplantation, has increased in the last decade. However, governments and NGOs of various countries are taking initiatives to encourage people to donate organs and save lives. New guidelines and rules for organ donation make the donation process more transparent and easier. The Human Resource & Services Administration launched Hospital Organ Donor Campaign in April 2020. This led to an increase in the number of organ donations from the previous year.

Asia Pacific is projected to be the fastest-growing regional market during the forecast period owing to the extensive research on stem cells to develop in vitro tissue and organs and improving healthcare infrastructure in countries, such as India, Thailand, the Philippines, and Indonesia.

Key Companies & Market Share Insights

The market is highly fragmented with the presence of many large-, small-, and medium-scale vendors. Major players are involved in new product launches, mergers & acquisitions, and regional expansion to gain maximum revenue share in the industry. Mergers and acquisitions support vendors in expanding their existing product portfolio and geographical reach. For instance, in May 2020, AbbVie acquired Allergan to strengthen its product portfolio and distribution channels.

Rising regulatory approvals for allografts, autologous grafts, and other materials along with the development of innovative products, such as 3D bioprinting for tissue and organ regeneration, have led to high demand for transplant products. For instance, in September 2020, Israel-based CollPlant Biotechnologies and United Therapeutics announced a collaboration to include 3D bioprinting in the development of human kidneys for transplant. Some of the prominent players in the global transplantation market include:

  • Stryker Corp.

  • Medtronic PLC

  • AbbVie Inc.

  • Zimmer Biomet

  • Novartis International AG

  • 21st Century Medicine

  • Biolife Solutions

  • Teva Pharmaceutical

  • Veloxis Pharmaceuticals

Transplantation Market Report Scope

Report Attribute


Market size value in 2021

USD 12.3 billion

Revenue forecast in 2028

USD 26.5 billion

Growth Rate

CAGR of 11.5% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2029

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion, volume in units, and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product type, application type, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Brazil; Mexico; South Africa; Saudi Arabia

Key companies profiled

Stryker Corp.; Medtronic PLC; AbbVie Inc.; Zimmer Biomet; Novartis International AG; 21st Century Medicine; Biolife Solutions; Teva Pharmaceutical; Veloxis Pharmaceuticals

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each sub-segment from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global transplantation market report on the basis of product type, application type, end-use, and region:

  • Product Type Outlook (Revenue, USD Billion, 2016 - 2028)

    • Tissue Products

    • Immunosuppressive Drugs

    • Preservation Solutions

  • Application Type Outlook (Revenue, USD Billion, 2016 - 2028)

    • Organ Transplant

    • Tissue Transplant

  • End-use Outlook (Revenue, USD Billion, 2016 - 2028)

    • Hospitals

    • Transplant Centers

    • Others

  • Regional Outlook (Revenue, USD Billion, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

      • Saudi Arabia

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.